244 related articles for article (PubMed ID: 21858179)
1. Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
Hoffmann LS; Schmidt PM; Keim Y; Hoffmann C; Schmidt HH; Stasch JP
PLoS One; 2011; 6(8):e23596. PubMed ID: 21858179
[TBL] [Abstract][Full Text] [Related]
2. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
[TBL] [Abstract][Full Text] [Related]
3. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E
PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808
[TBL] [Abstract][Full Text] [Related]
4. Dimerization region of soluble guanylate cyclase characterized by bimolecular fluorescence complementation in vivo.
Rothkegel C; Schmidt PM; Atkins DJ; Hoffmann LS; Schmidt HH; Schröder H; Stasch JP
Mol Pharmacol; 2007 Nov; 72(5):1181-90. PubMed ID: 17715400
[TBL] [Abstract][Full Text] [Related]
5. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
7. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
Bice JS; Keim Y; Stasch JP; Baxter GF
Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
[TBL] [Abstract][Full Text] [Related]
8. Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.
Tsai EJ; Liu Y; Koitabashi N; Bedja D; Danner T; Jasmin JF; Lisanti MP; Friebe A; Takimoto E; Kass DA
Circ Res; 2012 Jan; 110(2):295-303. PubMed ID: 22095726
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of soluble guanylyl cyclase in living cells proceeds without loss of haem and involves heterodimer dissociation as a common step.
Dai Y; Stuehr DJ
Br J Pharmacol; 2022 Jun; 179(11):2505-2518. PubMed ID: 33975383
[TBL] [Abstract][Full Text] [Related]
10. The molecular mechanism of heme loss from oxidized soluble guanylate cyclase induced by conformational change.
Pan J; Zhang X; Yuan H; Xu Q; Zhang H; Zhou Y; Huang ZX; Tan X
Biochim Biophys Acta; 2016 May; 1864(5):488-500. PubMed ID: 26876536
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.
Zhou Z; Pyriochou A; Kotanidou A; Dalkas G; van Eickels M; Spyroulias G; Roussos C; Papapetropoulos A
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1763-71. PubMed ID: 18757489
[TBL] [Abstract][Full Text] [Related]
13. Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.
Martin F; Baskaran P; Ma X; Dunten PW; Schaefer M; Stasch JP; Beuve A; van den Akker F
J Biol Chem; 2010 Jul; 285(29):22651-7. PubMed ID: 20463019
[TBL] [Abstract][Full Text] [Related]
14. Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.
Roy B; Mo E; Vernon J; Garthwaite J
Br J Pharmacol; 2008 Apr; 153(7):1495-504. PubMed ID: 18204474
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE.
Sürmeli NB; Müskens FM; Marletta MA
J Biol Chem; 2015 Jun; 290(25):15570-15580. PubMed ID: 25907555
[TBL] [Abstract][Full Text] [Related]
16. NO- and haem-independent soluble guanylate cyclase activators.
Schmidt HH; Schmidt PM; Stasch JP
Handb Exp Pharmacol; 2009; (191):309-39. PubMed ID: 19089335
[TBL] [Abstract][Full Text] [Related]
17. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
Stasch JP; Schmidt P; Alonso-Alija C; Apeler H; Dembowsky K; Haerter M; Heil M; Minuth T; Perzborn E; Pleiss U; Schramm M; Schroeder W; Schröder H; Stahl E; Steinke W; Wunder F
Br J Pharmacol; 2002 Jul; 136(5):773-83. PubMed ID: 12086987
[TBL] [Abstract][Full Text] [Related]
18. Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat.
Surmeli NB; Marletta MA
Chembiochem; 2012 May; 13(7):977-81. PubMed ID: 22474005
[TBL] [Abstract][Full Text] [Related]
19. Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Dasgupta A; Bowman L; D'Arsigny CL; Archer SL
Clin Pharmacol Ther; 2015 Jan; 97(1):88-102. PubMed ID: 25670386
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
Wang WZ; Jones AW; Wang M; Durante W; Korthuis RJ
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H521-32. PubMed ID: 23771693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
